Compare HQ & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HQ | BWAY |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | Singapore | Israel |
| Employees | 44 | 129 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.9M | 572.1M |
| IPO Year | N/A | N/A |
| Metric | HQ | BWAY |
|---|---|---|
| Price | $10.25 | $13.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.25 |
| AVG Volume (30 Days) | ★ 256.7K | 148.7K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $309.69 |
| Revenue Next Year | N/A | $26.21 |
| P/E Ratio | ★ N/A | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.29 | $10.61 |
| 52 Week High | $14.65 | $26.63 |
| Indicator | HQ | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 35.13 |
| Support Level | $9.38 | $11.90 |
| Resistance Level | $10.40 | $16.51 |
| Average True Range (ATR) | 1.56 | 0.52 |
| MACD | -0.16 | -0.21 |
| Stochastic Oscillator | 8.25 | 2.12 |
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.